Droxicam

屈恶昔康

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDroxicam
Drug Alias Name屈昔康DroflexDroxarFerpanPrecam +[9
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstaglandin synthase inhibitors
TargetsProstaglandin
Therapy Area/IndicationsRheumatic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesEsteve Pharmaceuticals LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsRheumatic Diseases

Other Information

ATC CodeM01AC04